These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11093572)
21. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori. Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895 [TBL] [Abstract][Full Text] [Related]
22. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study. Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890 [TBL] [Abstract][Full Text] [Related]
23. Can anti-Helicobacter pylori and anti-CagA antibodies be used to select patients with dyspepsia for gastroscopy? Manjunath SM; Desai ND; Alexander J; Patil S; Ughade S; Sawant P Trop Gastroenterol; 2006; 27(3):122-6. PubMed ID: 17310555 [TBL] [Abstract][Full Text] [Related]
24. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092 [TBL] [Abstract][Full Text] [Related]
25. The treatment of dyspepsia. Shearman DJ Aust Fam Physician; 1977 Aug; 6(8):1028-32. PubMed ID: 921613 [TBL] [Abstract][Full Text] [Related]
26. Frequency of Helicobacter pylori infection in dyspeptic patients in Libya. Bakka AS; El-Gariani AB; AbouGhrara FM; Salih BA Saudi Med J; 2002 Oct; 23(10):1261-5. PubMed ID: 12436134 [TBL] [Abstract][Full Text] [Related]
27. Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia. Ford AC; Moayyedi P; Jarbol DE; Logan RF; Delaney BC Aliment Pharmacol Ther; 2008 Sep; 28(5):534-44. PubMed ID: 18616641 [TBL] [Abstract][Full Text] [Related]
28. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886 [TBL] [Abstract][Full Text] [Related]
29. Nurse-led dyspepsia clinic using the urea breath test for Helicobacter pylori. Fraser A; Williamson S; Lane M; Hollis B N Z Med J; 2003 Jun; 116(1176):U479. PubMed ID: 12835807 [TBL] [Abstract][Full Text] [Related]
30. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164 [TBL] [Abstract][Full Text] [Related]
31. Implications for treatment: pH, Helicobacter pylori or alternative approaches? Chey WD Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():17-8, 21-4. PubMed ID: 15755271 [No Abstract] [Full Text] [Related]
32. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial. Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009 [TBL] [Abstract][Full Text] [Related]
33. [Non-ulcer dyspepsia and Helicobacter pylori infection]. Buljevac M; Banić M; Kujundzić M; Dominis M; Colić-Cvrlje V; Kardum D; Katicić M Lijec Vjesn; 2002 Sep; 124 Suppl 1():61-3. PubMed ID: 12592820 [TBL] [Abstract][Full Text] [Related]
34. Management of dyspepsia and peptic ulcer disease. Ryan SW Altern Ther Health Med; 2005; 11(5):26-9; quiz 30. PubMed ID: 16189945 [TBL] [Abstract][Full Text] [Related]
35. Implementation of a guideline versus use of individual prognostic factors to prioritize waiting lists for upper gastrointestinal endoscopy. Cardin F; Zorzi M; Terranova O Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):549-53. PubMed ID: 17556900 [TBL] [Abstract][Full Text] [Related]
36. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715 [TBL] [Abstract][Full Text] [Related]
37. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S; J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773 [TBL] [Abstract][Full Text] [Related]
39. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies? Gisbert JP; Olivares D; Jimenez I; Pajares JM Dig Liver Dis; 2006 Apr; 38(4):254-9. PubMed ID: 16309984 [TBL] [Abstract][Full Text] [Related]
40. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. Avidan B; Melzer E; Keller N; Bar-Meir S Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]